Guillaume Baxter
InvestorPartner at Sofinnova Partners
Paris, France
Writes $100K – $5M checks · typically $1.5M
Find your path to Guillaume
477 people in our graph share verified history with Guillaume — schools, employers, funds. One of them is your warm intro.
About
Guillaume Baxter is a Partner in Sofinnova's Industrial Biotech Strategy, focusing on industrial biotechnology and renewable chemistry; he joined in 2017 as a Senior Associate. He previously worked at Solvay in Brussels on sustainable energy and advanced materials, then at Solvay Ventures as Investment Manager. He holds master's degrees in Genetics-Immunology and Industrial Biotechnology plus qualifications in innovation management.
Contact· published on Guillaume's own website
Invests in
BiotechDeep TechNew Materials
Experience
- Sofinnova PartnersPartnercurrent2024 — presentParis, Île-de-France, France
- Sofinnova PartnersPrincipal2021 — 2024Paris, Île-de-France, France
- Sofinnova PartnersSenior Associate2017 — 2021Greater Paris Metropolitan Region
- GFBiochemicalsBoard Membercurrent2022 — present
- QoriumBoard Membercurrent2023 — presentMaastricht, Limburg, Netherlands
- Micropep TechnologiesBoard Membercurrent2018 — presentGreater Toulouse Metropolitan Area
- Bon VivantBoard Observercurrent2023 — present
- Protera BiosciencesBoard Observercurrent2020 — presentParis, Île-de-France, France
- MeiogenixBoard Observercurrent2021 — presentParis, Île-de-France, France
- DNA ScriptBoard Observer2015 — 2017Greater Paris Metropolitan Region
- SolvaySolvay Ventures - Europe Investment Manager / Secondement at Sofinnova Partners2012 — 2017Greater Paris Metropolitan Region
- SolvayBusiness Development and R&D Portfolio Leader2011 — 2012Brussels Metropolitan Area
- SolvayCorporate New Businesses - R&D Program management - Sustainable Energies2009 — 2011Brussels Metropolitan Area
- SolvayCorporate New Businesses - Market & Technology Scouting Officer2007 — 2009Brussels Metropolitan Area
- CNRSResearch Internship2004Université Technologie Compiègne - Department of Biological Engineering
- INSERMSummer Research Intern2003Faculté des Sciences Pharmaceutiques - Paris 5 Descartes - Biology of Nutrition
- CNRSSummer Research Intern2002Faculté des Sciences Pharmaceutiques - Paris 5 - Tumors Immunology Unit
Skills & more
+7 more
GeneticsCorporate Venture CapitalOpen InnovationTechnology ScoutingBioprocessingFermentation TechnologyGreen ChemistryFrom Guillaume's professional profile.
Colleagues at Sofinnova Partners
Frequently asked questions
- Who is Guillaume Baxter?
- Guillaume Baxter is a Partner in Sofinnova's Industrial Biotech Strategy, focusing on industrial biotechnology and renewable chemistry; he joined in 2017 as a Senior Associate. He previously worked at Solvay in Brussels on sustainable energy and advanced materials, then at Solvay Ventures as Investment Manager. He holds master's degrees in Genetics-Immunology and Industrial Biotechnology plus qualifications in innovation management.
- Where does Guillaume Baxter work?
- Guillaume Baxter is Partner at Sofinnova Partners.
- What does Guillaume Baxter invest in?
- Guillaume Baxter invests in Biotech, Deep Tech, New Materials.
- What check size does Guillaume Baxter write?
- Guillaume Baxter typically writes checks of $100K – $5M.
- Where did Guillaume Baxter go to school?
- Guillaume Baxter studied at Université de Technologie de Compiègne (UTC) (Master of Research Degree (DEA) (dual degree AgroParisTech), Biotechnology); Louvain School of Management (Executive Programme, Innovation Management); NEOMA Business School (Master's degree (dual degree UTC Compiègne ), Technology and Innovation Management).
Same school
Also attended Université de Technologie de Compiègne (UTC)24
+ 18 more
Also attended Louvain School of Management29
+ 23 more
Also attended NEOMA Business School107
+ 101 more
Also attended Université Paris Cité117
+ 111 more
Shared employers
Also worked at Micropep Technologies4
Also worked at Protera Biosciences3
Also worked at Meiogenix2
Also worked at DNA Script12
+ 6 more


























































